I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 5 studies | 29% ± 17% | |
| GABAergic neuron | 3 studies | 27% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 5 studies | 29% ± 17% | |
| GABAergic neuron | 3 studies | 27% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 25% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 94% | 3598.07 | 2473 / 2642 | 91% | 10.25 | 642 / 705 |
| prostate | 91% | 2177.87 | 223 / 245 | 82% | 5.91 | 412 / 502 |
| bladder | 95% | 2840.05 | 20 / 21 | 46% | 13.15 | 234 / 504 |
| esophagus | 69% | 2177.88 | 993 / 1445 | 33% | 2.60 | 60 / 183 |
| ureter | 0% | 0 | 0 / 0 | 100% | 21.45 | 1 / 1 |
| intestine | 74% | 4559.33 | 713 / 966 | 13% | 1.01 | 71 / 527 |
| uterus | 29% | 267.92 | 49 / 170 | 54% | 6.86 | 249 / 459 |
| ovary | 3% | 23.75 | 5 / 180 | 71% | 6.14 | 305 / 430 |
| tonsil | 0% | 0 | 0 / 0 | 64% | 6.94 | 29 / 45 |
| kidney | 4% | 25.52 | 4 / 89 | 56% | 47.43 | 506 / 901 |
| stomach | 41% | 1315.98 | 148 / 359 | 17% | 1.63 | 48 / 286 |
| blood vessel | 52% | 704.65 | 700 / 1335 | 0% | 0 | 0 / 0 |
| lung | 1% | 4.56 | 3 / 578 | 43% | 8.43 | 492 / 1155 |
| eye | 0% | 0 | 0 / 0 | 43% | 1.44 | 34 / 80 |
| breast | 1% | 4.05 | 3 / 459 | 24% | 1.45 | 269 / 1118 |
| pancreas | 0% | 0 | 0 / 328 | 24% | 2.47 | 42 / 178 |
| skin | 2% | 12.98 | 41 / 1809 | 21% | 1.01 | 100 / 472 |
| adrenal gland | 0% | 0 | 0 / 258 | 22% | 2.17 | 50 / 230 |
| heart | 22% | 144.67 | 186 / 861 | 0% | 0 | 0 / 0 |
| thymus | 0% | 0 | 0 / 653 | 14% | 2.09 | 85 / 605 |
| liver | 0% | 3.38 | 1 / 226 | 10% | 2.38 | 39 / 406 |
| adipose | 5% | 49.33 | 61 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 11.00 | 13 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0018105 | Biological process | peptidyl-serine phosphorylation |
| GO_0005622 | Cellular component | intracellular anatomical structure |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0004683 | Molecular function | calmodulin-dependent protein kinase activity |
| GO_0005516 | Molecular function | calmodulin binding |
| GO_0106310 | Molecular function | protein serine kinase activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | PNCK |
| Protein name | Pregnancy up-regulated nonubiquitous CaM kinase Calcium/calmodulin-dependent protein kinase type 1B (EC 2.7.11.17) (CaM kinase I beta) (CaM kinase IB) (CaM-KI beta) (CaMKI-beta) (Pregnancy up-regulated non-ubiquitously-expressed CaM kinase) |
| Synonyms | |
| Description | FUNCTION: Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade. In vitro phosphorylates CREB1 and SYN1/synapsin I. Phosphorylates and activates CAMK1 (By similarity). . |
| Accessions | H7BZQ5 C9J8P0 ENST00000370142.5 [Q6P2M8-2] ENST00000419804.5 C9JJ18 ENST00000458354.5 F8WAQ5 C9JEC5 C9JB09 C9J2B9 ENST00000439087.5 Q6P2M8 ENST00000434652.5 F8WBU7 ENST00000433470.5 ENST00000411968.5 ENST00000438984.5 ENST00000425526.5 ENST00000423545.1 ENST00000370150.5 [Q6P2M8-1] ENST00000447676.6 [Q6P2M8-5] ENST00000418241.5 ENST00000422811.5 ENST00000370145.8 [Q6P2M8-6] ENST00000340888.8 [Q6P2M8-1] |
